Elanco Animal Health Inc (ELAN)’s financial ratios: A comprehensive overview

In other words, the price has increased by $0.00 from its previous closing price. On the day, 2706200 shares were traded.

Ratios:

Our goal is to gain a better understanding of ELAN by taking a closer look at its different ratios. It provided that stocks Price–to–Cash (P/C) ratio for the trailing twelve months (TTM) is standing at 20.66 whereas its Price-to-Free Cash Flow (P/FCF) for the term is 55.51. For the most recent quarter (mrq), Quick Ratio is recorded 1.35 and its Current Ratio is at 2.75. In the meantime, Its Debt-to-Equity ratio is 0.95 whereas as Long-Term Debt/Eq ratio is at 0.94.

Upgrades & Downgrades

In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for the company, Stifel on January 05, 2024, Upgraded its rating to Buy and sets its target price to $20 from $13 previously.

On December 19, 2023, Jefferies started tracking the stock assigning a Buy rating and target price of $17.

Morgan Stanley Upgraded its Equal-Weight to Overweight on December 15, 2023, while the target price for the stock was maintained at $16.

Insider Transactions:

The insider trade also gives investors a glimpse into the future direction of stock prices, which can be beneficial to investors. A recent insider transaction in this stock occurred on Mar 08 ’24 when DOYLE WILLIAM F bought 15,000 shares for $16.30 per share. The transaction valued at 244,500 led to the insider holds 61,330 shares of the business.

Harrington Michael J bought 3,100 shares of ELAN for $50,494 on Mar 08 ’24. The Director now owns 77,594 shares after completing the transaction at $16.29 per share. On Mar 06 ’24, another insider, HOOVER R DAVID, who serves as the Director of the company, bought 20,000 shares for $16.14 each. As a result, the insider paid 322,808 and bolstered with 185,000 shares of the company.

Valuation Measures:

Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, ELAN now has a Market Capitalization of 7.27B and an Enterprise Value of 12.69B. For the stock, the TTM Price-to-Sale (P/S) ratio is 1.65 while its Price-to-Book (P/B) ratio in mrq is 1.17. Its current Enterprise Value per Revenue stands at 2.87 whereas that against EBITDA is -56.67.

Stock Price History:

Over the past 52 weeks, ELAN has reached a high of $16.88, while it has fallen to a 52-week low of $7.88. The 50-Day Moving Average of the stock is 15.84, while the 200-Day Moving Average is calculated to be 12.89.

Shares Statistics:

The stock has traded on average 4.25M shares per day over the past 3-months and 4.05M shares per day over the last 10 days, according to various share statistics. A total of 492.85M shares are outstanding, with a floating share count of 488.17M. Insiders hold about 0.97% of the company’s shares, while institutions hold 98.32% stake in the company. Shares short for ELAN as of Mar 15, 2024 were 12.98M with a Short Ratio of 2.93, compared to 11.97M on Feb 15, 2024. Therefore, it implies a Short% of Shares Outstanding of 2.63% and a Short% of Float of 3.20%.

Most Popular

[the_ad id="945"]